Deucravacitinib was safe and effective for treating moderate to severe scalp psoriasis over 16 weeks ... nasopharyngitis (14.6%), upper respiratory tract infections (11.7%), acne (9.7%), headache (7.8 ...
Some results have been hidden because they may be inaccessible to you